NCT05361668 2026-03-19
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Phase 2 Completed
Crinetics Pharmaceuticals Inc.
Big Ten Cancer Research Consortium
University of Kentucky
Camurus AB